Lipocalin-type prostaglandin D synthase in urine in Adriamycin-induced nephropathy of mice

Nephron - Physiology

Volumn 96, Issue 2, 2004, Pages

  Tsuchida, Takamasa ^a   Eguchi, Naomi ^b,c   Eguchi, Yutaka ^d   Numabe, Atsushi ^e   Nakajima, Hiroshi ^a   Oda, Hiroshi ^a   Seiki, Kousuke ^a   Hakamada Taguchi, Rie ^f   Urade, Yoshihiro ^b,c   Uehara, Yoshio ^f  

^a Maruha Nichiro Holdings Inc   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adriamycin; Albuminuria; Nephritis; Prostaglandin D synthase

Indexed keywords

ALBUMIN; CREATININE; DOXORUBICIN; LIPOCALIN; MESSENGER RNA; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYMURIA; FEMALE; GLOMERULOPATHY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; TAIL; TUBULAR DYSFUNCTION; URINALYSIS; URINARY EXCRETION;

ANIMALS; BODY WEIGHT; DOXORUBICIN; FEMALE; GLOMERULONEPHRITIS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY; MICE; MICE, INBRED ICR; ORGAN SIZE; RNA, MESSENGER;

EID: 11144355639     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076407     Document Type: Article

References (31)

1. Urade Y, Hayaishi O: Prostaglandin D synthase: Structure and function. Vitam Horm 2000;58:89-120.
2. Urade Y, Watanabe K, Hayaishi: Prostaglandin D, E, and F synthases. J Lipid Mediators Cell Signal 1995;12:257-273.
3. Eguchi Y, Eguchi N, Oda H, Seiki K, Kijima Y, Matsu-ura Y, Urade Y, Hayaishi O: Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 1997;94:14689-14694.
4. Hoffmann A, Nimtz M, Conradt S: Molecular characterization of beta-trace protein in human serum and urine: A potential diagnostic marker for renal disease. Glycobiology 1997;7:499-506.
5. Melegos DN, Grass L, Pierratos A, Diamandis EP: Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 1999;53:32-37.
6. Priem F, Althaus H, Birnbaum M, Sinha P, Conradt HS, Jung K: Beta-trace protein in serum: A new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem 1999;45:567-568.
7. Hirawa N, Uehara Y, Ikeda T, Gomi T, Hamano K, Totsuka Y, Yamakado M, Takagi M, Eguchi N, Oda H, Seiki K, Nakajima H, Urade Y: Urinary prostaglandin D synthase (betatrace) excretion increases in the early-stage of diabetes mellitus. Nephron 2001;87:321-327.
8. Hamano K, Totsuka Y, Ajima M, Gomi T, Ikeda T, Hirawa N, Eguchi Y, Yamakado M, Takagi M, Nakajima H, Oda H, Seiki K, Eguchi N, Urade Y, Uehara Y: Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients. Nephron 2002;92:77-85.
9. Hirawa N, Uehara Y, Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, Takagi M, Oda H, Seiki K, Urade Y, Umemura S: Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension 2002;39/2:449-454.
10. Grond J, Weening JJ, Elema JD: Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Lab Invest 1984;51:277-285.
11. Meyer TW, Rennke HG: Increased singlenephron protein excretion after renal ablation in nephrotic rats. Am J Physiol 1988;255/6/2:F1243-F1248.
12. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-496.
13. Kunitomo M, Yamaguchi Y, Matsushima K, Futagawa Y, Bando Y: Hyperlipidemic effects of adriamycin in rats. Jpn J Pharmacol 1985;39:323-329.
14. Bertelli R, Ginevri F, Gusmano R, Ghiggeri GM: Cytotoxic effect of adriamycin and agarose-coupled adriamycin on glomerular epithelial cells: Role of free radicals. In Vitro Cell Dev Biol 1991;27A:799-804.
15. Dinneen S, Gerstein H: Microalbuminuria and mortality in NIDDM: A systematic review of the literature (abstract). Diabetes 1995;44 (suppl 1):124A.
16. Ruggenenti P, Remuzzi G: The role of protein traffic in the progression of renal diseases. Annu Rev Med 2000;51:315-327.
17. Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT: The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int 1982;21:730-738.
18. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
19. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH: Experimental focal segmental glomerulosclerosis in mice. Nephron 1998;78:440-452.
20. Oda H, Eguchi N, Urade Y, Hayaishi O: Quantitative sandwich enzyme-linked immunosorbent assay for human secretory prostaglandin D synthase (beta-trace). Proc Jpn Acad 1996; 72(ser B):108-111.
21. Uusitupa M, Sitonen O, Penttila K: Proteinuria in newly diagnosed type 2 diabetic patients. Diabetes Care 1987;10:191-194.
22. Alzaid AA: Microalbuminuria in patients with NIDDM: An overview. Diabetes Care 1996;19:79-89.
23. Siebert PD, Larrick JW: Competitive PCR. Nature 1992;359:557-558.
24. Raij J, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137-143.
25. Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Oshima N, Oka K, Ikeda T, Goto A, Toyo-Oka T, Kizuki K, Omata M: Long-term infusion of kallikrein attenuates renal injury in Dahl saltsensitive rats. Hypertension 1994;24:770-778.
26. 2 production and identification of prostaglandin H synthase within canine mast cell granule. Am J Physiol 1992;263:L168-L176.
27. 2 on hemodynamics, renal function, and blood gas analyses. Am J Obstet Gynecol 1987;156:843-851.
28. Tobian L, Uehara Y, Iwai J: Prostaglandin alterations in barely hypertensive Dahl S rats. Trans Assoc Am Physicians 1985;98:378-383.
29. 2 inhibits inducible nitric oxide synthase expression in vascular smooth muscle cells. Circ Res 1998;82:204-209.
30. Craven PS, DeRubertis FR, Melhem M: Nitric oxide in diabetic nephropathy. Kidney Int Suppl 1997;60:S46-S53.
31. 2 on iNOS induction in rat mesenteric artery. Life Sci 2000;66:2173-2182.